Frederike W. Riemslagh

Frederike W. Riemslagh

Auto-generated profile, based on publicly available information

Frederike W. Riemslagh

Institute of Molecular Life Sciences, University of Colorado, Anschutz Medical Campus, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CKCassie L. Kemmler
Cassie L. Kemmler
FRFréderike W. Riemslagh
Fréderike W. Riemslagh
HMHannah Moran
Hannah Moran
CMChristian Mosimann
Christian Mosimann
The heart is the first functional organ to form during vertebrate development. Congenital heart defects are the most common type of human birth defect, many originating as anomalies in early heart development. The zebrafish model provides an accessible vertebrate system to study early heart morphogenesis and to gain new insights into the mechanisms of congenital disease. Although composed of only two chambers compared with the four-chambered mammalian heart, the zebrafish heart integrates the core processes and cellular lineages central to cardiac development across vertebrates. The rapid, translucent development of zebrafish is amenable to in vivo imaging and genetic lineage tracing techniques, providing versatile tools to study heart field migration and myocardial progenitor addition and differentiation. Combining transgenic reporters with rapid genome engineering via CRISPR-Cas9 allows for functional testing of candidate genes associated with congenital heart defects and the discovery of molecular causes leading to observed phenotypes. Here, we summarize key insights gained through zebrafish studies into the early patterning of uncommitted lateral plate mesoderm into cardiac progenitors and their regulation. We review the central genetic mechanisms, available tools, and approaches for modeling congenital heart anomalies in the zebrafish as a representative vertebrate model.

27 August 2014 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
LFLauren G. Friedman
Lauren G. Friedman
FRFréderike W. Riemslagh
Fréderike W. Riemslagh
JSJosefa M. Sullivan
Josefa M. Sullivan
RMRoxana Mesias
Roxana Mesias
FWFrances M. Williams
Frances M. Williams
DBDeanna L. Benson
Deanna L. Benson

13 December 2014 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
RHRenate K Hukema
Renate K Hukema
FRFréderike W Riemslagh
Fréderike W Riemslagh
SMShamiram Melhem
Shamiram Melhem
HLHerma C van der Linde
Herma C van der Linde
LSLies-Anne Wfm Severijnen
Lies-Anne Wfm Severijnen
JSJohn C van Swieten
John C van Swieten

2 September 2022 in Science Advances
Verified
Journal Article
Open access
KMKenny Mattonet
Kenny Mattonet
FRFréderike W. Riemslagh
Fréderike W. Riemslagh
SGStefan Guenther
Stefan Guenther
KPKarin D. Prummel
Karin D. Prummel
GKGokul Kesavan
Gokul Kesavan
DSDidier Y. R. Stainier
Didier Y. R. Stainier
Endothelial specification is a key event during embryogenesis; however, when, and how, endothelial cells separate from other lineages is poorly understood. In zebrafish, Npas4l is indispensable for endothelial specification by inducing the expression of the transcription factor genesetsrp,tal1, andlmo2. We generated a knock-in reporter in zebrafishnpas4lto visualize endothelial progenitors and their derivatives in wild-type and mutant embryos. Unexpectedly, we find that innpas4lmutants,npas4lreporter–expressing cells contribute to the pronephron tubules. Single-cell transcriptomics and live imaging of the early lateral plate mesoderm in wild-type embryos indeed reveals coexpression of endothelial and pronephron markers, a finding confirmed by creERT2-based lineage tracing. Increased contribution ofnpas4lreporter–expressing cells to pronephron tubules is also observed intal1andlmo2mutants and is reversed innpas4lmutants injected withtal1mRNA. Together, these data reveal that Npas4l/Tal1/Lmo2 regulate the fate decision between the endothelial and pronephron lineages.

10 March 2015 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SGSusanna M.I. Goorden
Susanna M.I. Goorden
EAElisabeth Abs
Elisabeth Abs
CBCaroline F. Bruinsma
Caroline F. Bruinsma
FRFréDerike W. Riemslagh
FréDerike W. Riemslagh
GWGeeske M. van Woerden
Geeske M. van Woerden
YEYpe Elgersma
Ype Elgersma
Target of rapamycin complex 1 (TORC1) is an important regulator of neuronal function. However, whereas a modest activation of the TORC1 signaling pathway has been shown to affect synaptic plasticity, learning and memory, the effect of TORC1 hypo-activation is less clear. This knowledge is particularly important since TORC1 inhibitors may hold great promise for treating a variety of disorders, including developmental disorders, aging-related disorders, epilepsy and cancer. Such treatments are likely to be long lasting and could involve treating young children. Hence, it is pivotal that the effects of sustained TORC1 inhibition on brain development and cognitive function are determined. Here, we made use of constitutive and conditional Rheb1 mutant mice to study the effect of prolonged and specific reduction in the TORC1 pathway. We show that Rheb1 mutant mice show up to 75% reduction in TORC1 signaling, but develop normally and show intact synaptic plasticity and hippocampus-dependent learning and memory. We discuss our findings in light of current literature in which the effect of pharmacological inhibition of TORC1 is studied in the context of synaptic plasticity and learning. We conclude that in contrast to TORC1 hyper-activity, cognitive function is not very sensitive to sustained and specific down-regulation of TORC1 activity.

1 February 2021 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
FRFréderike W. Riemslagh
Fréderike W. Riemslagh
ETEsmay C. van der Toorn
Esmay C. van der Toorn
RVRob F. M. Verhagen
Rob F. M. Verhagen
AMAlex Maas
Alex Maas
LBLaurens W. J. Bosman
Laurens W. J. Bosman
RWRob Willemsen
Rob Willemsen
The hexanucleotide G4C2 repeat expansion in the first intron of the C9ORF72 gene accounts for the majority of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) cases. Numerous studies have indicated the toxicity of dipeptide repeats (DPRs), which are produced via repeat-associated non-AUG (RAN) translation from the repeat expansion, and accumulate in the brain of C9FTD/ALS patients. Mouse models expressing the human C9ORF72 repeat and/or DPRs show variable pathological, functional and behavioral characteristics of FTD and ALS. Here, we report a new Tet-on inducible mouse model that expresses 36× pure G4C2 repeats with 100-bp upstream and downstream human flanking regions. Brain-specific expression causes the formation of sporadic sense DPRs aggregates upon 6 months of dox induction, but no apparent neurodegeneration. Expression in the rest of the body evokes abundant sense DPRs in multiple organs, leading to weight loss, neuromuscular junction disruption, myopathy and a locomotor phenotype within the time frame of 4 weeks. We did not observe any RNA foci or pTDP-43 pathology. Accumulation of DPRs and the myopathy phenotype could be prevented when 36× G4C2 repeat expression was stopped after 1 week. After 2 weeks of expression, the phenotype could not be reversed, even though DPR levels were reduced. In conclusion, expression of 36× pure G4C2 repeats including 100-bp human flanking regions is sufficient for RAN translation of sense DPRs, and evokes a functional locomotor phenotype. Our inducible mouse model suggests that early diagnosis and treatment are important for C9FTD/ALS patients. This article has an associated First Person interview with the first author of the paper.